Trial intelligence / Profile preview

BIND study of polystyrene sulfonate interaction with amitriptyline

NL-OMON49827Phase 4Active, not recruiting

Sponsor
Deventer Ziekenhuis
Start
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of sodium polystyrene sulfonate and amitriptyline (2 arms), sponsored by Deventer Ziekenhuis. Primary endpoints: Maximum plasma concentration of amitriptyline and Area under the concentration-time curve from 0 to 8 hours. Started Aug 2020; status: active, not recruiting.

02

Drugs

sodium polystyrene sulfonateamitriptyline

Beyond the preview

Go deeper on NL-OMON49827.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON49827.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call